Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Biocytogen Pharmaceuticals announced the grand opening of a new 37,000 square foot facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
read more
Tuesday, December 08, 2020
Beijing Biocytogen, Biocytogen Boston Corp, announced they have reached an agreement with Xencor, Inc., for the licensing of Biocytogen's fully human antibody RenMab/RenLite Mouse platform.
read more
Biocytogen Pharmaceuticals announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth.
read more
Thursday, December 03, 2015
BioDelivery Sciences International has appointed Joseph (Jody) M. Lockhart as Vice President of Manufacturing and Supply Chain.
read more
Tuesday, February 14, 2023
Biodextris Inc., a subsidiary of Clean Biologics SAS, announced the development of a new industrial-scale vaccine and biologics development, manufacturing and packaging plant (CDMO).
read more
Wednesday, March 30, 2016
Biodextris Inc. has announced its suite of services and commitment to building a full service contract organization. The new contract research organization (CRO) provides analytical and process development services for vaccines and biologics ...
read more
This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform with BioDuro’s expertise in discovery chemistry, biology and DMPK to accelerate the development of next-generation peptides.
read more
BioDuro announced it has established a joint venture with Cenra API Solutions to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.
read more
Monday, December 09, 2019
BioDuro has announced the appointment of Kent Payne, Ph.D., as President of its CMC Global Solutions business unit.
read more
BioDuro announced the acquisition of Molecular Response and its translational oncology research platform, including its biobank of more than 100,000 viable tumor specimens.
read more
BioDuro, LLC, a global contract research organization (CRO) focused on fully outsourced turnkey discovery and development services in Oncology, Inflammatory Disease, Metabolism and CNS for pharmaceutical partners, has announced the formal launch of ...
read more
Tuesday, November 18, 2025
BioDuro announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company’s commitment to strengthening its peptide technology platform to meet ...
read more
BioDuro has broadly launched new antibody- and cell-based therapy discovery services.
read more
Tuesday, October 09, 2018
BioDuro has established a new drug discovery center for chemistry and biology in San Diego, CA.
read more
Thursday, November 12, 2015
BioDuro, a global CRO focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, announced the merger of its US operations with Formex, LLC, a provider of pharmaceutical API ...
read more